C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.
Fiche publication
Date publication
mars 2023
Journal
Research and practice in thrombosis and haemostasis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MOULIN Thierry
Tous les auteurs :
Billoir P, Siguret V, Fron EM, Drouet L, Crassard I, Marlu R, Barbieux-Guillot M, Morange PE, Robinet E, Metzger C, Wolff V, André-Kerneis E, Klapczynski F, Martin-Bastenaire B, Pico F, Menard F, Ellie E, Freyburger G, Rouanet F, Allano HA, Godenèche G, Mourey G, Moulin T, Berruyer M, Derex L, Trichet C, Runavot G, Le Querrec A, Viader F, Cluet-Dennetiere S, Husein TT, Donnard M, Macian-Montoro F, Ternisien C, Guillon B, Laplanche S, Zuber M, Peltier JY, Tassan P, Roussel B, Canaple S, Scavazza E, Gaillard N, Triquenot Bagan A, Le Cam Duchez V
Lien Pubmed
Résumé
Cerebral venous sinus thrombosis (CVST) is a rare disease with highly variable clinical presentation and outcomes. Clinical studies suggest a role of inflammation and coagulation in CVST outcomes. The aim of this study was to investigate the association of inflammation and hypercoagulability biomarkers with CVST clinical manifestations and prognosis.
Mots clés
D-dimer, cerebral venous sinus thrombosis, high-sensitivity C-reactive protein, thrombin generation assay
Référence
Res Pract Thromb Haemost. 2023 03;7(3):100130